Literature DB >> 8344365

Variable binding affinities of listeriolysin O peptides for the H-2Kd class I molecule.

B T Wipke1, S C Jameson, M J Bevan, E G Pamer.   

Abstract

Previously we used the peptide-binding motif for the murine class I major histocompatibility complex molecule H-2Kd to identify a nonamer peptide of the Listeria monocytogenes listeriolysin (LLO) protein that was recognized by cytotoxic T lymphocytes (CTL) in association with H-2Kd. Eleven nonamer peptides contained in the LLO sequence were synthesized and one, LLO 91-99, proved to be a CTL target. Using peptide binding competition assays with H-2Kd-restricted CTL, we show that 3 out of the 11 LLO peptides, including the CTL epitope, have a high binding affinity for H-2Kd; 2 of 11 peptides have approximately 10-fold lower affinity, while the remaining 6 peptides have no or very low affinity for H-2Kd. Single residue changes were made in the LLO 91-99 peptide and two other LLO peptides to identify non-anchor amino acids that might interfere with peptide binding. In addition, we used the LLO peptides which bound well to H-2Kd to attempt to restimulate a secondary CTL response from L. monocytogenes-primed spleen cells. Only LLO 91-99 was able to induce such a response. Thus only a fraction of nonamer peptides which fit the original binding motif have a high affinity for the H-2Kd class I molecule, and only a fraction of these serve as CTL epitopes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8344365     DOI: 10.1002/eji.1830230842

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  12 in total

1.  Hierarchy of Epstein-Barr virus-specific cytotoxic T-cell responses in individuals carrying different subtypes of an HLA allele: implications for epitope-based antiviral vaccines.

Authors:  R Khanna; S R Burrows; A Neisig; J Neefjes; D J Moss; S L Silins
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

2.  Mutations inside but not outside the peptide binding cleft of the H-2 Ld molecule affect CTL recognition and binding of the nucleoprotein peptide from the lymphocytic choriomeningitis virus.

Authors:  C E Hioe; D M McKinney; J A Frelinger; M McMillan
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

3.  Differential effects of flanking residues on presentation of epitopes from chimeric peptides.

Authors:  C C Bergmann; L Tong; R Cua; J Sensintaffar; S Stohlman
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

4.  Conditional lethality yields a new vaccine strain of Listeria monocytogenes for the induction of cell-mediated immunity.

Authors:  Zhongxia Li; Xinyan Zhao; Darren E Higgins; Fred R Frankel
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

5.  Systemic immunity and mucosal immunity are induced against human immunodeficiency virus Gag protein in mice by a new hyperattenuated strain of Listeria monocytogenes.

Authors:  M V Rayevskaya; F R Frankel
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

6.  Elimination of the listeriolysin O-directed immune response by conservative alteration of the immunodominant listeriolysin O amino acid 91 to 99 epitope.

Authors:  H G Bouwer; M Moors; D J Hinrichs
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

7.  A nonamer peptide derived from Listeria monocytogenes metalloprotease is presented to cytolytic T lymphocytes.

Authors:  D H Busch; H G Bouwer; D Hinrichs; E G Pamer
Journal:  Infect Immun       Date:  1997-12       Impact factor: 3.441

Review 8.  Listeriolysin O as a strong immunogenic molecule for the development of new anti-tumor vaccines.

Authors:  Rui Sun; Yuqin Liu
Journal:  Hum Vaccin Immunother       Date:  2013-02-11       Impact factor: 3.452

9.  Pathogenicity and immunogenicity of a Listeria monocytogenes strain that requires D-alanine for growth.

Authors:  R J Thompson; H G Bouwer; D A Portnoy; F R Frankel
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

10.  Protective immunity to Listeria monocytogenes infection mediated by recombinant Listeria innocua harboring the VGC locus.

Authors:  Walid Mohamed; Shneh Sethi; Svetlin Tchatalbachev; Ayub Darji; Trinad Chakraborty
Journal:  PLoS One       Date:  2012-04-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.